Jasper Therapeutics

Jasper is a biotechnology company focused on targeting mast cells and stem cells to treat chronic diseases.

Founded 2018

Redwood City, United States 41 employees IPO Total: $270.00M Biotechnology, Health Care +2

General Information

Company Name Jasper Therapeutics

Founded Year 2018

Location

Redwood City, United States

Employees 41

Industries Biotechnology, Health Care, Health and Wellness +1

Funding Stage IPO

Business Model B2B

Revenue Model Product Sales, Licensing

Social

BounceWatch is an independent company data service, not affiliated with Jasper Therapeutics. To contact Jasper Therapeutics, visit jaspertx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Jasper Therapeutics compare?

A PDF of Jasper Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Jasper Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

From the desk

Is Jasper Therapeutics on your competitive set?

Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.

Book a 7-day Readout

Discover More

United States Market

Market Signals All Companies

Biotechnology

Industry Signals All Companies in United States

Jasper Therapeutics Alternatives

All Signals Trend Reports

About Jasper Therapeutics

Jasper Therapeutics is a biotechnology company, founded in 2018, and headquartered in the United States. The company is driven by a mission to develop therapies targeting mast cells and stem cells, aiming to offer safer and potentially curative treatments for chronic diseases.

With a focus on conditions related to these cell types, Jasper Therapeutics is assembling a highly experienced team of biotech experts, partnering with prominent academic institutions, and attracting a robust syndicate of healthcare-focused investors. Their goal is to introduce innovative solutions in the realms of biotechnology, health care, and pharmaceuticals.

Recently, the company secured a significant financial boost with a $30.00M post-IPO equity investment as of September 1, 2025. This infusion of capital is expected to accelerate their research and development efforts, further solidifying their position as a pioneering force within the healthcare and wellness sectors.

Business keywords: Mast Cell Therapy, Stem Cell Therapy, Chronic Disease Treatment, Hematopoietic Stem Cells, Gene Therapy, Monogenetic Diseases, eHSCs Platform, Conditioning Agents, Allogeneic Transplant, Autologous Transplant, JSP191, Clinical Development, Healthtech Innovation, Curative Therapy

Services & Products

Targeted anti-KIT antibody development

Clinical studies for chronic diseases

Therapy development for mast cell-driven diseases

Target Customers

Patients with chronic mast cell-driven diseases Healthcare providers treating chronic immunological conditions Allergy and asthma specialists

Funding Rounds & Investors (5)

View All

Funding Stage	Amount	Investors	Lead Investors	Date
Post-IPO Equity	$30.00M	-		01 Sep 2025
Post-IPO Equity	$50.00M	10	Abingworth, Qiming Venture Partners USA +8	01 Feb 2024
Post-IPO Equity	$90.00M	-		01 Jan 2023
Spac Private Placement	$100.00M	1	Amplitude Healthcare Acquisition Corporation	01 May 2021
Series A	Undisclosed	3	TSVC, Citadel +1	01 Jan 2020

Jasper Therapeutics Alternatives & Competitors

View All Alternatives

Jasper Therapeutics vs

Sana Biotechnology, Inc. United States

Focused on creating and delivering engineered cells as medicines for patients

IPO

257 employees

Biotechnology, Health Care

Compare Jasper Therapeutics vs Sana Biotechnology, Inc.

Jasper Therapeutics vs

Orchard Therapeutics - U.S. United Kingdom

Dedicated to transforming the lives of patients with severe and other genetic diseases through innov...

Post-IPO Equity

238 employees

Biotechnology, Health Care

Compare Jasper Therapeutics vs Orchard Therapeutics - U.S.

Jasper Therapeutics vs

Orca Bio United States

Transforming allogeneic cell therapy for patients with cancer and autoimmune diseases.

Series D

327 employees

Health Care, Pharmaceutical

Compare Jasper Therapeutics vs Orca Bio

Also compare with:

Barinthus Biotherapeutics View all alternatives

FAQ About Jasper Therapeutics

Jasper is a biotechnology company focused on targeting mast cells and stem cells to treat chronic diseases.

Jasper Therapeutics was founded in 2018.

Jasper Therapeutics is headquartered in Redwood City, United States.

Jasper Therapeutics operates in Biotechnology, Health Care, Health and Wellness and Pharmaceutical. Its work centres on Mast Cell Therapy, Stem Cell Therapy, Chronic Disease Treatment and Hematopoietic Stem Cells. Its customers include Patients with chronic mast cell-driven diseases, Healthcare providers treating chronic immunological conditions and Allergy and asthma specialists.

Jasper Therapeutics has a B2B business model. Its revenue comes from Product Sales and Licensing.

Jasper Therapeutics has approximately 41 employees.

Jasper Therapeutics has completed 5 funding rounds, raising a total of $270.00M. The latest funding stage is IPO.

Jasper Therapeutics offers: Targeted anti-KIT antibody development, Clinical studies for chronic diseases, Therapy development for mast cell-driven diseases.

Top alternatives and competitors to Jasper Therapeutics include Sana Biotechnology, Inc., Orchard Therapeutics - U.S., Orca Bio, Garuda Therapeutics, Barinthus Biotherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

Jasper Therapeutics and Sana Biotechnology, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Jasper Therapeutics, https://bouncewatch.com/company/jasper-therapeutics, updated 9 June 2026. When citing, please name BounceWatch and link this page.